Moving averages
SMA 200$4.13-24.21%
Company profile
Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company is headquartered in Hoersholm, Denmark.
SectorHealthcare
IndustryBiotechnology
Market cap$27.86M
P/E ratioNone
EPS$-1.03
Beta0.254
Dividend yield0.00%
52-week high$12.15
52-week low$2.52
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 44
VRTX
Vertex Pharmaceuticals Inc
RSI 44
CRSP
CRISPR Therapeutics AG
RSI 39
IOVA
Iovance Biotherapeutics Inc
RSI 63
MRNA
Moderna Inc
RSI 61
VKTX
Viking Therapeutics Inc
RSI 42
SRPT
Sarepta Therapeutics Inc
RSI 53
EDIT
Editas Medicine Inc
RSI 41
NVAX
Novavax Inc
RSI 54
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 42
RSI alerts for EVAX
Get an email the moment Evaxion Biotech AS crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 15 August 2026 at 7:31 AM EDT